Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,014 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy.
Pace D, Khatami A, Attard-Montalto S, Voysey M, Finn A, Faust SN, Heath PT, Borrow R, Snape MD, Pollard AJ. Pace D, et al. Among authors: finn a. Vaccine. 2016 Dec 7;34(50):6350-6357. doi: 10.1016/j.vaccine.2016.10.038. Epub 2016 Oct 28. Vaccine. 2016. PMID: 28029540 Clinical Trial.
Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series.
Oliver JL, Sadorge C, Boisnard F, Snape MD, Tomlinson R, Mann R, Rudd P, Bhakthavalsala S, Faust SN, Heath PT, Hughes SM, Borrow R, Thomas S, Finn A. Oliver JL, et al. Among authors: finn a. Vaccine. 2020 Jul 31;38(35):5718-5725. doi: 10.1016/j.vaccine.2020.06.015. Epub 2020 Jul 10. Vaccine. 2020. PMID: 32654902 Clinical Trial.
Safety of a new conjugate meningococcal C vaccine in infants.
Lakshman R, Jones I, Walker D, McMurtrie K, Shaw L, Race G, Choo S, Danzig L, Oster P, Finn A. Lakshman R, et al. Among authors: finn a. Arch Dis Child. 2001 Nov;85(5):391-7. doi: 10.1136/adc.85.5.391. Arch Dis Child. 2001. PMID: 11668101 Free PMC article. Clinical Trial.
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
Pace D, Khatami A, McKenna J, Campbell D, Attard-Montalto S, Birks J, Voysey M, White C, Finn A, Macloed E, Faust SN, Kent AL, Heath PT, Borrow R, Snape MD, Pollard AJ. Pace D, et al. Among authors: finn a. BMJ. 2015 Apr 1;350:h1554. doi: 10.1136/bmj.h1554. BMJ. 2015. PMID: 25832102 Free PMC article. Clinical Trial.
Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.
Borrow R, Goldblatt D, Finn A, Southern J, Ashton L, Andrews N, Lal G, Riley C, Rahim R, Cartwright K, Allan G, Miller E. Borrow R, et al. Among authors: finn a. Infect Immun. 2003 Oct;71(10):5549-55. doi: 10.1128/IAI.71.10.5549-5555.2003. Infect Immun. 2003. PMID: 14500473 Free PMC article. Clinical Trial.
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, Heath PT, Lewis DJ, Pollard AJ, Turner DP, Bazaz R, Ganguli A, Havelock T, Neal KR, Okike IO, Morales-Aza B, Patel K, Snape MD, Williams J, Gilchrist S, Gray SJ, Maiden MC, Toneatto D, Wang H, McCarthy M, Dull PM, Borrow R. Read RC, et al. Among authors: finn a. Lancet. 2014 Dec 13;384(9960):2123-31. doi: 10.1016/S0140-6736(14)60842-4. Epub 2014 Aug 18. Lancet. 2014. PMID: 25145775 Clinical Trial.
1,014 results